Mukka Proteins Board Approves Financial Results, Acquires Full Ownership of Subsidiaries
Mukka Proteins approved unaudited financial results for Q3 FY26. The company will acquire full ownership of subsidiaries Ento Proteins Private Limited and Haris Marine Products Private Limited, with completion expected by June 30, 2026. The Board also amended its insider trading code of conduct.
The acquisition of full ownership of subsidiaries is a strategic move that could enhance consolidation and operational efficiency, impacting the company's structure and potentially its future performance.
The company reported financial results and approved strategic acquisitions to make subsidiaries wholly owned, which is positive for growth and control.
Mukka Proteins Limited announced the outcome of its Board Meeting held on February 12, 2026. The Board approved the unaudited financial results for the quarter and nine months ended December 31, 2025, for both standalone and consolidated entities. The limited review report from the statutory auditors was also enclosed.
In significant strategic moves, the company approved the acquisition of additional equity shares in Ento Proteins Private Limited (EPPL) and Haris Marine Products Private Limited (HMPPL). These acquisitions will make both EPPL and HMPPL wholly owned subsidiaries of Mukka Proteins. The indicative time period for the completion of these acquisitions is June 30, 2026.
Additionally, the Board approved an amendment to the Company's Code of Conduct for Regulating, Monitoring, and Reporting of Trading by Insiders, with the amended code made available on the company's website.
The Board Meeting commenced at 4:00 PM and concluded at 4:45 PM.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.